Dopamine D1 and D2 receptor antagonism effects on rat ultrasonic vocalizations

Behavioural Brain Research

Volumn 252, Issue , 2013, Pages 252-259

  Ringel, Lauren E ^a   Basken, Jaime N ^a   Grant, Laura M ^a,b   Ciucci, Michelle R ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

Antagonism; Dopamine; Rat; Receptor; Sensorimotor control; Ultrasonic vocalization

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; ETICLOPRIDE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; RECEPTOR;

ACOUSTICS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICIPATION; ARTICLE; ASSOCIATION; AUDITORY SYSTEM PARAMETERS; BEHAVIOR CHANGE; BODY MOVEMENT; CATALEPSY DESCENT TIME; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DOPAMINERGIC TRANSMISSION; EMOTION; FEMALE; MALE; MOTOR CONTROL; NERVOUS SYSTEM PARAMETERS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REWARD; SEMANTICS; SENSORIMOTOR FUNCTION; SOUND TRANSMISSION; ULTRASONIC VOCALIZATION; VOCALIZATION; ANALYSIS OF VARIANCE; ANIMAL; ANTAGONISM; AUDITORY STIMULATION; CATALEPSY; DRUG EFFECT; DRUG INTERACTION; LONG EVANS RAT; METABOLISM; PREFRONTAL CORTEX; PSYCHOPHYSICS; REACTION TIME; SENSORIMOTOR CONTROL; ULTRASOUND;

ANTAGONISM; DOPAMINE; RAT; RECEPTOR; SENSORIMOTOR CONTROL; ULTRASONIC VOCALIZATION;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; FEMALE; FREEZING REACTION, CATALEPTIC; MALE; PREFRONTAL CORTEX; PSYCHOACOUSTICS; RATS; RATS, LONG-EVANS; REACTION TIME; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; ULTRASONICS; VOCALIZATION, ANIMAL;

EID: 84880003657     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.06.006     Document Type: Article

References (42)

1. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
2. Bergman H., Deuschl G. Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back. Mov Disord 2002, 17(Suppl. 3):S28-S40.
3. Chesselet M.F., Delfs J.M. Basal ganglia and movement disorders: an update. Trends Neurosci 1996, 19:417-422.
4. Darley F.L., Aronson A.E., Brown J.R. Motor speech signs in neurologic disease. Med Clin North Am 1968, 52:835-844.
5. Forrest K., Weismer G., Turner G.S. Kinematic, acoustic, and perceptual analyses of connected speech produced by parkinsonian and normal geriatric adults. J Acoust Soc Am 1989, 85:2608-2622.
6. Harel B., Cannizzaro M., Snyder P.J. Variability in fundamental frequency during speech in prodromal and incipient Parkinson's disease: a longitudinal case study. Brain Cogn 2004, 56:24-29. 10.1016/j.bandc.2004.05.002.
7. Ho A.K., Iansek R., Marigliani C., Bradshaw J.L., Gates S. Speech impairment in a large sample of patients with Parkinson's disease. Behav Neurol 1998, 11:131-137.
8. Plowman-Prine E.K., Sapienza C.M., Okun M.S., Pollock S.L., Jacobson C., Wu S.S., et al. The relationship between quality of life and swallowing in Parkinson's disease. Mov Disord 2009, 24:1352-1358. 10.1002/mds.22617.
9. Stewart C., Winfield L., Hunt A., Bressman S.B., Fahn S., Blitzer A., et al. Speech dysfunction in early Parkinson's disease. Mov Disord 1995, 10:562-565. 10.1002/mds.870100506.
10. Ferrer I., Martinez A., Blanco R., Dalfo E., Carmona M. Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease. J Neural Transm 2010, 10.1007/s00702-010-0482-8.
11. Kompoliti K., Wang Q.E., Goetz C.G., Leurgans S., Raman R. Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology 2000, 54:458-462.
12. D'Alatri L., Paludetti G., Contarino M.F., Galla S., Marchese M.R., Bentivoglio A.R. Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment. J Voice 2008, 22:365-372. 10.1016/j.jvoice.2006.10.010.
13. Pinto S., Ozsancak C., Tripoliti E., Thobois S., Limousin-Dowsey P., Auzou P. Treatments for dysarthria in Parkinson's disease. Lancet Neurol 2004, 3:547-556. 10.1016/S1474-4422(04)00854-3.
14. Beaulieu J.M., Gainetdinov R.R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 2011, 63:182-217. 10.1124/pr.110.002642.
15. Ciucci M.R., Connor N.P. Dopaminergic influence on rat tongue function and limb movement initiation. Exp Brain Res 2009, 194:587-596. 10.1007/s00221-009-1736-2.
16. Burgdorf J., Knutson B., Panksepp J., Ikemoto S. Nucleus accumbens amphetamine microinjections unconditionally elicit 50kHz ultrasonic vocalizations in rats. Behav Neurosci 2001, 115:940-944.
17. Natusch C., Schwarting R.K. Using bedding in a test environment critically affects 50kHz ultrasonic vocalizations in laboratory rats. Pharmacol Biochem Behav 2010, 96:251-259. 10.1016/j.pbb.2010.05.013.
18. 2-like receptors in amphetamine-induced rat ultrasonic vocalizations. Psychopharmacology (Berlin) 2013, 225:853-868. 10.1007/s00213-012-2871-1.
19. Plowman E.K., Maling N., Rivera B.J., Larson K., Thomas N.J., Fowler S.C., et al. Differential sensitivity of cranial and limb motor function to nigrostriatal dopamine depletion. Behav Brain Res 2013, 237:157-163. 10.1016/j.bbr.2012.09.031.
20. 2 receptor antagonists on laryngeal neurophysiology in the rat. J Neurophysiol 2009, 102:1193-1205. 10.1152/jn.00121.2009.
21. Hammer M.J., Barlow S.M. Laryngeal somatosensory deficits in Parkinson's disease: implications for speech respiratory and phonatory control. Exp Brain Res 2010, 201:401-409. 10.1007/s00221-009-2048-2.
22. Ciucci M.R., Ma S.T., Fox C., Kane J.R., Ramig L.O., Schallert T. Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol: a preliminary study. Behav Brain Res 2007, 182:284-289. 10.1016/j.bbr.2007.02.020.
23. Ciucci M.R., Ahrens A.M., Ma S.T., Kane J.R., Windham E.B., Woodlee M.T., et al. Reduction of dopamine synaptic activity: degradation of 50kHz ultrasonic vocalization in rats. Behav Neurosci 2009, 123:328-336. 10.1037/a0014593.
24. Brudzynski S.M., Pniak A. Social contacts and production of 50kHz short ultrasonic calls in adult rats. J Comp Psychol 2002, 116:73-82.
25. Wohr M., Houx B., Schwarting R.K., Spruijt B. Effects of experience and context on 50kHz vocalizations in rats. Physiol Behav 2008, 93:766-776. 10.1016/j.physbeh.2007.11.031.
26. Bialy M., Rydz M., Kaczmarek L. Precontact 50kHz vocalizations in male rats during acquisition of sexual experience. Behav Neurosci 2000, 114:983-990.
27. Burgdorf J., Wood P.L., Kroes R.A., Moskal J.R., Panksepp J. Neurobiology of 50kHz ultrasonic vocalizations in rats: electrode mapping, lesion, and pharmacology studies. Behav Brain Res 2007, 182:274-283. 10.1016/j.bbr.2007.03.010.
28. Burgdorf J., Kroes R.A., Moskal J.R., Pfaus J.G., Brudzynski S.M., Panksepp J. Ultrasonic vocalizations of rats (Rattus norvegicus) during mating, play, and aggression: behavioral concomitants, relationship to reward, and self-administration of playback. J Comp Psychol 2008, 122:357-367. 10.1037/a0012889.
29. Burgdorf J., Panksepp J., Moskal J.R. Frequency-modulated 50kHz ultrasonic vocalizations: a tool for uncovering the molecular substrates of positive affect. Neurosci Biobehav Rev 2011, 35:1831-1836. 10.1016/j.neubiorev.2010.11.011.
30. Brudzynski S.M. Ultrasonic calls of rats as indicator variables of negative or positive states: acetylcholine-dopamine interaction and acoustic coding. Behav Brain Res 2007, 182:261-273. 10.1016/j.bbr.2007.03.004.
31. Brudzynski S.M. Ethotransmission: communication of emotional states through ultrasonic vocalization in rats. Curr Opin Neurobiol 2013, 10.1016/j.conb.2013.01.014.
32. Riede T. Subglottal pressure, tracheal airflow, and intrinsic laryngeal muscle activity during rat ultrasound vocalization. J Neurophysiol 2011, 106:2580-2592. 10.1152/jn.00478.2011.
33. Johnson A.M., Ciucci M.R., Russell J.A., Hammer M.J., Connor N.P. Ultrasonic output from the excised rat larynx. J Acoust Soc Am 2010, 128:EL75-EL79. 10.1121/1.3462234.
34. Ciucci M.R., Vinney L., Wahoske E.J., Connor N.P. A translational approach to vocalization deficits and neural recovery after behavioral treatment in Parkinson disease. J Commun Disord 2010, 43:319-326. 10.1016/j.jcomdis.2010.04.004.
35. Russell J.A., Ciucci M.R., Connor N.P., Schallert T. Targeted exercise therapy for voice and swallow in persons with Parkinson's disease. Brain Res 2010, 1341:3-11. 10.1016/j.brainres.2010.03.029.
36. Morelli M., Di Chiara G. Catalepsy induced by SCH 23390 in rats. Eur J Pharmacol 1985, 117:179-185.
37. Wright J.M., Gourdon J.C., Clarke P.B. Identification of multiple call categories within the rich repertoire of adult rat 50kHz ultrasonic vocalizations: effects of amphetamine and social context. Psychopharmacology (Berlin) 2010, 211:1-13. 10.1007/s00213-010-1859-y.
38. Knutson B., Burgdorf J., Panksepp J. Ultrasonic vocalizations as indices of affective states in rats. Psychol Bull 2002, 128:961-977.
39. Abbruzzese G., Berardelli A. Sensorimotor integration in movement disorders. Mov Disord 2003, 18:231-240. 10.1002/mds.10327.
40. Sanberg P.R., Bunsey M.D., Giordano M., Norman A.B. The catalepsy test: its ups and downs. Behav Neurosci 1988, 102:748-759.
41. Ahrens A.M., Ma S.T., Maier E.Y., Duvauchelle C.L., Schallert T. Repeated intravenous amphetamine exposure: rapid and persistent sensitization of 50kHz ultrasonic trill calls in rats. Behav Brain Res 2009, 197:205-209. 10.1016/j.bbr.2008.08.037.
42. Cenci M.A., Whishaw I.Q., Schallert T. Animal models of neurological deficits: how relevant is the rat?. Nat Rev Neurosci 2002, 3:574-579. 10.1038/nrn877.